tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Kestra Medical Unveils Positive ASSURE Study Results

Story Highlights
Kestra Medical Unveils Positive ASSURE Study Results

Meet Your ETF AI Analyst

Kestra Medical Technologies Ltd. ( (KMTS) ) just unveiled an announcement.

On November 10, 2025, Kestra Medical Technologies announced the results of the ASSURE WCD Clinical Evaluation Post-Approval Study (ACE-PAS) at the American Heart Association Scientific Sessions in New Orleans. The study, which is the largest real-world examination of wearable defibrillators to date, confirmed the strong safety and effectiveness of Kestra’s ASSURE device in clinical practice. Key findings included a 100% success rate in converting ventricular tachycardia and fibrillation events, a low inappropriate-shock rate, and high patient compliance. These results underscore the critical role of wearable defibrillators in protecting patients at risk of sudden cardiac death, potentially informing future clinical practices.

The most recent analyst rating on (KMTS) stock is a Hold with a $27.00 price target. To see the full list of analyst forecasts on Kestra Medical Technologies Ltd. stock, see the KMTS Stock Forecast page.

Spark’s Take on KMTS Stock

According to Spark, TipRanks’ AI Analyst, KMTS is a Neutral.

Kestra Medical Technologies Ltd. shows strong revenue growth and improving gross margins, which are positive indicators. However, the company’s ongoing profitability challenges and increased operating expenses weigh heavily on its financial performance. The technical analysis suggests bullish momentum, but valuation concerns due to negative earnings and lack of dividends limit the stock’s attractiveness.

To see Spark’s full report on KMTS stock, click here.

More about Kestra Medical Technologies Ltd.

Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.

Average Trading Volume: 262,121

Technical Sentiment Signal: Strong Buy

Current Market Cap: $1.35B

See more insights into KMTS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1